AR111482A1 - VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS - Google Patents
VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODSInfo
- Publication number
- AR111482A1 AR111482A1 ARP180101004A ARP180101004A AR111482A1 AR 111482 A1 AR111482 A1 AR 111482A1 AR P180101004 A ARP180101004 A AR P180101004A AR P180101004 A ARP180101004 A AR P180101004A AR 111482 A1 AR111482 A1 AR 111482A1
- Authority
- AR
- Argentina
- Prior art keywords
- product
- chitosan
- mastitis
- treatment
- sol
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Reivindicación 1: Un producto para prevenir o tratar un trastorno mamario en un animal hembra no humano, caracterizado porque comprende una cantidad efectiva de un compuesto mixto de polímero de sol-gel que comprende quitosano, un polímero hidrófilo separado del quitosano, un agente gelificante y un medio adecuado, y el producto que comprende adicionalmente un polisiloxano. Reivindicación 13: El producto de conformidad con la reivindicación 1, caracterizado porque el compuesto mixto de polímero de sol-gel comprende además uno o más agentes antimicrobianos. Reivindicación 14: El producto de conformidad con la reivindicación 13, caracterizado porque el agente antimicrobiano se selecciona del grupo que consiste de un macrólido, una cefalosporina, un antibiótico lincosaminida, una fluoroquinolona, una tetraciclina, una penicilina, una espectinomicina, una sulfonamida, un cloranfenicol, un análogo sintético fluorado de tiamfenicol y una mezcla de los mismos.Claim 1: A product for preventing or treating a breast disorder in a non-human female animal, characterized in that it comprises an effective amount of a mixed compound of sol-gel polymer comprising chitosan, a hydrophilic polymer separated from chitosan, a gelling agent and a suitable medium, and the product additionally comprising a polysiloxane. Claim 13: The product according to claim 1, characterized in that the mixed sol-gel polymer compound further comprises one or more antimicrobial agents. Claim 14: The product according to claim 13, characterized in that the antimicrobial agent is selected from the group consisting of a macrolide, a cephalosporin, an antibiotic lincosaminide, a fluoroquinolone, a tetracycline, a penicillin, a spectinomycin, a sulfonamide, a chloramphenicol, a fluorinated synthetic analogue of thiamphenicol and a mixture thereof.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762487601P | 2017-04-20 | 2017-04-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR111482A1 true AR111482A1 (en) | 2019-07-17 |
Family
ID=67439471
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP180101004A AR111482A1 (en) | 2017-04-20 | 2018-04-19 | VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS |
Country Status (1)
| Country | Link |
|---|---|
| AR (1) | AR111482A1 (en) |
-
2018
- 2018-04-19 AR ARP180101004A patent/AR111482A1/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DOP2019000110A (en) | 1,2,4–2,4,5–TRI-SUBSTITUTED TRIAZOLONES | |
| DOP2017000137A (en) | BENZAMIDES SUBSTITUTED WITH 1,3-THIAZOL-2-ILO. | |
| CL2016002812A1 (en) | Use of 3-2,3,5,6-tetrafluoro-3-trifluoromethoxy-biphenyl-4-ylcarbamoyl-thiophene-2-carboxylic acid to prepare a medicament useful for treating an eye disease that is uveitis, dry eye or caused by a adenovirus composition formulation. | |
| UY37687A (en) | VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS | |
| CL2019002255A1 (en) | 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides. | |
| MX2020012041A (en) | Pharmaceutical formulation. | |
| UY36973A (en) | SOL-GEL POLYMERIC COMPOUNDS AND THEIR USES | |
| SA517381996B1 (en) | Composition for a wound dressing | |
| UY37460A (en) | 1,2,4-TRIAZOLONS WITH ANALATION IN 4 AND 5 | |
| BR112016013684A2 (en) | AQUEOUS OR HYDROCOLOID SOLUTION, METHOD FOR INCREASE THE VISCOSITY OF A COMPOSITION AND METHOD FOR TREATMENT OF A MATERIAL | |
| PE20171238A1 (en) | STEREOCHEMICALLY ENRICHED COMPOSITIONS FOR NUCLEIC ACIDS ADMINISTRATION | |
| TN2018000119A1 (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
| CU20200008A7 (en) | SUBSTITUTE DIHYDROOXADIAZINONE COMPOUNDS USEFUL IN THE TREATMENT OF HYPERPROLIFERATIVE DISEASES, METHODS FOR PREPARING SUCH COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| ECSP20081995A (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEMOGLOBINOPATHIES AND THALASEMIAS | |
| BR112017006406A2 (en) | compositions and methods for the treatment and prophylaxis of surgical site infections | |
| CL2018001590A1 (en) | Pharmaceutical compositions comprising some phenylaminopyrimidine derivative. | |
| MX2021001921A (en) | Feed compositions and feed additive compositions for aquaculture species. | |
| EA201991501A1 (en) | ANTI-MICROBIAL COMPOSITION CONTAINING OLIGODYNAMIC METAL | |
| ES2895910T3 (en) | Multiphase compositions | |
| CR20190396A (en) | Antimicrobial, non-thrombogenic polymer compositions | |
| MX2018014087A (en) | Palpable marker composition. | |
| AR111482A1 (en) | VETERINARY COMPOSITIONS FOR USE IN THE TREATMENT OF MASTITIS AND ASSOCIATED METHODS | |
| CL2021001096A1 (en) | Methods for treating myelodysplastic syndrome. (divisional application no. 202000196) | |
| BR112018005842A2 (en) | Viscoelasticity constituent | |
| CL2022003206A1 (en) | Quinolone-derived compounds and their use for the treatment of cancer (div. sol. 202102501) |